To assess NO involvement in the pathophysiology of T1DM, we treated Biobreeding rats, an animal model of autoimmune diabetes, with the general NOS inhibitor L-NMMA at early stages of the insulitis process. This evidence concerns the gene NOS2 and type 1 diabetes mellitus.